IKT vs MPWR · $215.2M cap vs P/E 112, rev $1.78B
Inhibikase Therapeutics Inc (IKT) versus Monolithic Power Systems Inc (MPWR) — a side-by-side from cached financials, not a winner call.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
Latest reported MPWR revenue for 2026-06-30 was $1.78B. Net income was $450.5M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
IKT currently screens at market cap $215.2M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
Not investment advice. Open the IKT and MPWR stock pages for the full models.
Not investment advice.